ApoE genotype and protease-inhibitor-associated hyperlipidaemia [9]

Lancet

Volumn 354, Issue 9172, 1999, Pages 76-

  Behrens, G ^a   Schmidt, H H J ^a   Stoll, M ^a   Schmidt, R E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; PROTEINASE INHIBITOR;

FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033519936     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)75347-2     Document Type: Letter

References (5)

1. RK Lister M Youle DR Nair AF Winder MHA Rustin Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitors Lancet 353 1999 1678
2. A Carr K Samaras S Burton A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 1998 F51 F58
3. G Behrens A Dejam H Schmidt Impaired glucose tolerance, beta cell function, and lipid metabolism in HIV-patients under treatment with protease inhibitors AIDS 13 1999 F63 F70
4. CDS Mamotte M Sturm JI Foo FM van Bockxmeer RR Taylor Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygoites Am J Physiol 276 1999 553 557
5. EH Corder K Robertson L Lannfelt HIV-infected subject with E4 allele for apoE have excess dementia and peripheral neuropathy Nat Med 4 1993 1182 1184